Drug Resistance
Data from Northwestern University provide new insights into drug resistance
Published in Medical Letter on the CDC and FDA, December 23rd, 2007
"Unfortunately, contemporary use of vancomycin has been tempered by increasing rates of resistance, leading researchers to investigate other antimicrobial options. Telavancin is a novel semisynthetic lipoglycopeptide antibiotic undergoing FDA review for complicated skin and skin-structure infections; this agent is also in phase 3 clinical trials for the treatment of hospital-acquired pneumonia caused...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Biomanufacturing
Research on biomanufacturing described by scientists at University of London - Cervical Cancer
Updated Analysis of 2001 Epoetin Alfa Study Posted - Clinical Research
The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research - HealthTrans
Concerned about Adverse Events HealthTrans Removes Avandia - The Medicines Company
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results - Thrombocytopenic Purpura
Data on thrombocytopenic purpura described by researchers at Northwestern University, Medical Department - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
